Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - CHOOKASZIAN DENNIS
Last Updated 
20-Mar-17
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

CHOOKASZIAN DENNIS: Declared Holdings
Company/RelationshipReportedShares  Ownership
CME Group Inc.
Director
NasdaqGS:CME
(historical quotes, profile, other insiders)
27-Jun-162,139  Direct
Allscripts Healthcare Solutions
Director
NasdaqGS:MDRX
(historical quotes, profile, SEC, other insiders)
29-May-15127,567  Direct
PREMIER TECHS GP USD0.001
Director
NasdaqCM:PRZM
(historical quotes, profile, other insiders)
8-Feb-17454,288  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
8-Feb-17 17,862PRZM Purchase at $0.31 per share.
(Cost of $5,537)
7-Feb-17 16,969PRZM Purchase at $0.33 per share.
(Cost of $5,599)
6-Feb-17 52,111PRZM Purchase at $0.34 per share.
(Cost of $17,717)
6-Feb-17 52,111PRZM Purchase at $0.33 per share.
(Cost of $17,196)
3-Feb-17 30,000PRZM Purchase at $0.35 per share.
(Cost of $10,500)
18-Jan-17 5,200PRZM Purchase at $0.32 - $0.33 per share.
(Cost of about $1,690)
17-Jan-17 16,200PRZM Purchase at $0.34 - $0.35 per share.
(Cost of about $5,589)
3-Jan-17 2,005PRZM Purchase at $0.29 per share.
(Cost of $581)
30-Dec-16 9,653PRZM Purchase at $0.28 per share.
(Cost of $2,702)
27-Jun-16 1,075CME Acquisition (Non Open Market) at $0 per share.
25-Jun-15 1,064CME Acquisition (Non Open Market) at $0 per share.
29-May-15 14,215MDRX Acquisition (Non Open Market) at $0 per share.


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?